JPMorgan sees 100% upside in overlooked cancer drug stock
Covered by 1 source · 1 article
The bank just put a big number on a small biotech company, and the target rests on a newly launched drug.
Covered by
Covered by 1 source · 1 article
The bank just put a big number on a small biotech company, and the target rests on a newly launched drug.
